Area of research
Oncology · Immunology
Research interest
Research interests include CAR-T cell therapy research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, and Cancer Immunotherapy and Biomarkers.
Early recognition of the APECED rash can accelerate the diagnosis of APECED
Diagnosis of Mosaic Tuberous Sclerosis Complex Using Next-Generation Sequencing of Subtle or Unusual Cutaneous Findings.
Data from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
Aberrant type 1 immunity drives susceptibility to mucosal fungal infections
Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.
Thyroid nodules in xeroderma pigmentosum patients: a feature of premature aging.
First Somatic <i>PRKAR1A</i> Defect Associated With Mosaicism for Another <i>PRKAR1A</i> Mutation in a Patient With Cushing Syndrome.
Host-Pathogen Interactions in Human Polyomavirus 7‒Associated Pruritic Skin Eruption.
Somatic Mutations in <i>UBA1</i> and Severe Adult-Onset Autoinflammatory Disease
Impaired angiogenesis and extracellular matrix metabolism in autosomal-dominant hyper-IgE syndrome.
Identification of Small Molecule Enhancers of Immunotherapy for Melanoma.
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion.
Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance
Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance.
GATA-2-deficient mast cells limit IgE-mediated immediate hypersensitivity reactions in human subjects.
Birt-Hogg-Dubé syndrome initially diagnosed as tuberous sclerosis complex.
Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production
Recurrent Mutations in the Basic Domain of TWIST2 Cause Ablepharon Macrostomia and Barber-Say Syndromes
Activated STING in a Vascular and Pulmonary Syndrome
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
A Case of Severe Hyperaldosteronism Caused by a De Novo Mutation Affecting a Critical Salt Bridge Kir3.4 Residue
Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma
AKT1 Gene Mutation Levels Are Correlated with the Type of Dermatologic Lesions in Patients with Proteus Syndrome